Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $1.43 in the last session, down -1.38% from day before closing price of $1.45. In other words, the price has decreased by -$1.38 from its previous closing price. On the day, 2.58 million shares were traded.
Ratios:
We take a closer look at ALLO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.54 and its Current Ratio is at 8.54. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $11 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 14 ’25 when Chang David D sold 46,668 shares for $1.96 per share. The transaction valued at 91,469 led to the insider holds 5,276,569 shares of the business.
Beneski Benjamin Machinas sold 5,488 shares of ALLO for $10,839 on Mar 14 ’25. The SVP, Chief Technical Officer now owns 218,507 shares after completing the transaction at $1.98 per share. On Mar 14 ’25, another insider, Beneski Benjamin Machinas, who serves as the Officer of the company, bought 5,488 shares for $1.97 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 15534.09 while its Price-to-Book (P/B) ratio in mrq is 0.72.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $4.01, while it has fallen to a 52-week low of $1.23. The 50-Day Moving Average of the stock is -18.30%, while the 200-Day Moving Average is calculated to be -37.88%.
Shares Statistics:
A total of 212.21M shares are outstanding, with a floating share count of 139.53M. Insiders hold about 35.78% of the company’s shares, while institutions hold 63.35% stake in the company.
